Cromofarm nasal spray 2% 5ml — Made in Ukraine — Free Delivery

Prevention and treatment of acute and chronic seasonal or year-round allergic rhinitis, hay fever.

Immediately before use, you need to hold the vial with the preparation in the palm of your hand to warm it to body temperature. before the introduction of the preparation, you must carefully clean the nose. during the use of the preparation, the vial is held vertically, with the nozzle up. before use, remove the protective cap, then place the tip of the nozzle in the nasal passage, lightly press the fingers to inject the preparation. during injection, it is recommended to inhale slightly through the nose. after use, the bottle is closed with a protective cap.

One injection of Cromofarm spray contains 2 mg of sodium cromoglycate (2.7 drops of the preparation solution).

Adults and children over the age of 5 years: 1 injection into each nasal passage 3-4 times a day. If necessary, the frequency of use in adults can be increased up to 6 times a day.

For seasonal allergic rhinitis, treatment should be started as soon as the first symptoms appear, or used prophylactically before exposure of the patient to a known allergen. After achieving a therapeutic effect, a gradual lengthening of the intervals between doses of the preparation is possible. Cancellation should be carried out gradually over 1 week. The duration of use depends on the type and severity of the disease.

Hypersensitivity to cromoglycic acid and other components of the preparation; pregnancy and lactation, children under 5 years; severe renal and / or liver failure; nasal polyps.

Respiratory system disorders: irritation or burning of the mucous membrane of the nasal cavity, frequent sneezing, coughing, rhinorrhea, rarely - nosebleeds, mild dryness in the throat, stridor or difficulty breathing, coughing, choking, ulceration of the nasal mucosa;

disorders of the immune system: extremely rarely, anaphylactic reactions, angioedema, difficulty swallowing, swelling of the face, lips, tongue or eyelids, arthralgia can occur;

disorders of the skin and subcutaneous tissue: skin rash, urticaria, skin itching, exanthema;

gastrointestinal disorders: change in taste sensations, dysphagia, nausea, abdominal pain;

neurological disorders: dizziness, headache, migraine;

cardiac disorders: lowering blood pressure;

others: lacrimation.

In acute inflammation and during an exacerbation of a chronic process, the preparation should be used in combination with antihistamines or corticosteroids. the patient should be warned about the need for regular use of the preparation. in renal failure, monitoring of functional indicators should be carried out; if necessary, the dose can be reduced.

Accidental ingestion of Kromopharm is safe. No special measures other than medical supervision are required.

If the integrity of the vial is violated, as well as if the solution becomes cloudy, the preparation should not be used.

Use during pregnancy and lactation. Sodium cromoglycate is excreted in breast milk in small quantities, therefore, when using the preparation during breastfeeding, the risk of harmful effects on young children is minimal or practically absent. However, the use of the preparation during pregnancy, especially in the first trimester, or during lactation is possible when, in the opinion of the doctor, the expected benefit to the mother outweighs the potential risk to the fetus or child.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Does not affect.

Children. Do not use in children under 5 years of age. Treatment with the preparation  in children older than 5 years is possible only after consulting a doctor.

There are no data on negative preparation  interactions of sodium cromoglycate (in the form of a nasal spray) with other preparations. when Kromopharm is included in therapy with antihistamines, β-agonists, glucocorticoids and theophylline, the dose of the latter can be reduced.

Cases of overdose have not been established, but overdose may increase adverse reactions. symptomatic treatment.

In a place protected from light at a temperature of 15-25 ° C.